GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Price-to-Operating-Cash-Flow

ChemoMetec AS (FRA:CHY) Price-to-Operating-Cash-Flow : 51.69 (As of Jun. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is ChemoMetec AS Price-to-Operating-Cash-Flow?

As of today (2025-06-02), ChemoMetec AS's share price is €70.20. ChemoMetec AS's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.36. Hence, ChemoMetec AS's Price-to-Operating-Cash-Flow Ratio for today is 51.69.

The historical rank and industry rank for ChemoMetec AS's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:CHY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 21.05   Med: 53.29   Max: 194.05
Current: 52.11

During the past 13 years, ChemoMetec AS's highest Price-to-Operating-Cash-Flow Ratio was 194.05. The lowest was 21.05. And the median was 53.29.

FRA:CHY's Price-to-Operating-Cash-Flow is ranked worse than
84.58% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 19.01 vs FRA:CHY: 52.11

ChemoMetec AS's Cash Flow from Operations per share for the six months ended in Dec. 2024 was €0.68. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.36.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of ChemoMetec AS was 20.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 40.20% per year.

During the past 13 years, ChemoMetec AS's highest 3-Year average Operating Cash Flow per Share Growth Rate was 90.00% per year. The lowest was -69.40% per year. And the median was 24.20% per year.


ChemoMetec AS Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ChemoMetec AS's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Price-to-Operating-Cash-Flow Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.74 136.05 74.49 52.61 41.09

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 52.61 - 41.09 -

Competitive Comparison of ChemoMetec AS's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, ChemoMetec AS's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChemoMetec AS's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's Price-to-Operating-Cash-Flow falls into.


;
;

ChemoMetec AS Price-to-Operating-Cash-Flow Calculation

ChemoMetec AS's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=70.20/1.358
=51.69

ChemoMetec AS's Share Price of today is €70.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.36.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

ChemoMetec AS Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ChemoMetec AS Business Description

Traded in Other Exchanges
Address
Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.